QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,501 signal articles · 104 in last 24h · 107,954 total before filter · latest 25m ago
104last 24h
2589last 7d
488● bullish (7d)
239● bearish (7d)
202publishers
AllMacro223Earnings1617M&A119Regulatory16Product10Analyst25
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Universal Music Group Record Low; Roblox Slumps  | Stock Movers
Bloomberg9d agobearishVIDEO
Universal Music Group Record Low; Roblox Slumps | Stock Movers

On this episode of Stock Movers: - Universal Music Group (UMG NA) plummeted to their lowest level since listing, after the company reported disappointing subscription revenue growth. The world's largest record label's subscription revenues grew 16.6% in constant currency, including the impact of its purchase of Downtown Music Holdings, but analysts had expected a 19.2% increase. - Roblox (RBLX) shares are lower after the video-game company's second-quarter results disappointed on key metrics, including users and hours engaged. It also gave a forecast for both bookings and revenue that was weaker than expected. - Reddit (RDDT) shares are moving after it projected revenue in the current quarter revenue that beat Wall Street estimates, but shares fell after the social media company failed to announce any new data licensing agreements.

Westinghouse Electric Files Confidentially for IPO
The Wall Street Journal9d agoneutral
Westinghouse Electric Files Confidentially for IPO

Nuclear technology and services supplier Westinghouse Electric has confidentially filed a draft registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock

Mastercard Q2 Earnings Call Highlights
MarketBeat9d agoneutral
Mastercard Q2 Earnings Call Highlights

Mastercard (NYSE:MA) reported second-quarter 2026 results that exceeded its expectations, supported by continued consumer and business spending, cross-border activity and demand for its value-added services. On a non-GAAP, currency-neutral basis, net revenue rose 12% year over year, adjusted net in

How Big Is Tesla's China Business, Anyway?
The Wall Street Journal9d agoneutral
How Big Is Tesla's China Business, Anyway?

Some Tesla executives have been told to prepare for a separation of the automaker's China business ahead of a potential merger with SpaceX, the Journal reports. The China business brought in $8.86 billion of sales in the first half of 2026, accounting for 17.

Private credit roundup: Earnings hold up as defaults, redemptions remain elevated
Reuters9d agoneutral
Private credit roundup: Earnings hold up as defaults, redemptions remain elevated

Ares Capital and Blue Owl Capital reported resilient second-quarter results this week, while Ares Management posted record fundraising, highlighting continued institutional demand for private credit despite rising defaults, ‌retail redemptions and liquidity concerns. Ares Management, one of the industry's largest players, raised a record $36 billion ‌in the second quarter, including $23.7 billion for its credit strategies. Assets under management rose 17% from a year earlier to $671.3 billion.

2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching
TipRanks9d agobullish
2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching

The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%

Novo Nordisk Stock Drops After Drug Fails in Cardiovascular Trial
The Wall Street Journal9d agobearish
Novo Nordisk Stock Drops After Drug Fails in Cardiovascular Trial

Novo Nordisk shares dropped after the Danish drugmaker said an experimental medicine didn't reduce risk of major adverse cardiovascular events in a late-stage trial. The company's Denmark-listed stock was down nearly 10%, while its American depositary receipts fell about 9% in premarket trading in New York.

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.
Barrons.com9d agobullish
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.

AbbVie shares took a hit Friday after costs related to the drugmaker’s acquisition of Apogee Therapeutics forced a cut to its full-year profit outlook. Second-quarter revenue jumped 10% to nearly $17 billion, beating the $16.8 billion consensus estimate among analysts polled by FactSet. AbbVie posted adjusted earnings of $3.65 a share, narrowly ahead of Wall Street’s call for $3.60.